Nighttime ADHD drug tested in kids with epilepsy

NCT ID NCT07594652

Recruiting now Symptom relief Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This study tests whether Jornay PM, a stimulant taken at night for ADHD, is safe and helpful for children who also have epilepsy. About 25 kids will take the medication and be monitored for improvements in ADHD symptoms. The goal is to ease attention and hyperactivity without triggering seizures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: methylphenidate hydrochloride (Jornay PM)
What this could lead to: If it works, this could offer a safe way to treat ADHD symptoms in children with epilepsy, improving focus and behavior.
What could go wrong: This is a small, early-phase study with only 25 participants. It may not show clear benefits, and stimulants can sometimes increase seizure risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD - ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD - ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY

Contacts and locations

Locations

Kennedy Krieger Institute
RECRUITING

Baltimore, Maryland, 21205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.